Causalgia

G6_CAUSALGIA

causalgia: Complex regional pain syndrome type 2 (CRPS2), or causalgia is a form of complex regional pain syndrome that develops after damage to a peripheral nerve and is characterized by spontaneous pain, allodynia and hyperalgesia , not necessarily limited to the territory of the injured nerve, as well as at some point, edema, changes in skin blood flow or sudomotor dysfunction in the pain area.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G56.4 Hospital discharge: ICD-9 — 3544 Cause of death: ICD-10 — G56.4 Cause of death: ICD-9 — 3544 2 out of 7 registries used, show all original rules.	634
4. Check minimum number of events None	634
5. Include endpoints None	634
6. Filter based on genotype QC (FinnGen only)	634

Control definitions (FinnGen only)

Control exclude: G6_NERPLEX

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: G56
Name in latin: Causalgia

NAME	G6_CAUSALGIA
CONTROL_EXCLUDE	G6_NERPLEX
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G564
HD_ICD_9	3544
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G564
COD_ICD_9	3544
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Causalgia based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	4108	2491	1591
Only index persons	3917	2418	1499
Unadjusted period prevalence (%)
Whole population	0.06	0.07	0.04
Only index persons	0.08	0.09	0.06
Median age at first event (years)
Whole population	47.72	47.94	47.37
Only index persons	47.48	47.68	47.16

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	634	437	197
Unadjusted period prevalence (%)	0.13	0.15	0.09
Median age at first event (years)	46.81	46.03	48.53

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
558: Matched controls
5581

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

G56.4

ICD-10 Finland

Causalgia

4503599627370496.0

323.0

537

M89.0

ICD-10 Finland

Algoneurodystrophy

206.6

192.8

191

N03AX12

ATC

gabapentin; oral

20.2

191.1

329

370

N03AX16

ATC

pregabalin; oral

15.8

180.9

379

658

G56.0

ICD-10 Finland

Carpal tunnel syndrome

34.1

122.7

162

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

210.8

116.4

117

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

14.8

116.3

212

221

N06AX21

ATC

duloxetine; oral

12.2

109.8

223

288

N02AX02

ATC

tramadol; systemic, rectal

6.6

91.9

387

1432

N06AA09

ATC

amitriptyline; systemic

9.8

73.9

164

228

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

212.7

73.1

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

141.8

70.8

ACC51

NOMESCO Finland

Release of median nerve

196.3

67.7

N02AA05

ATC

oxycodone; systemic

8.2

67.6

169

282

M79.6

ICD-10 Finland

Pain in limb

4.9

66.2

327

1257

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

41.5

65.7

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

6.3

56.4

172

369

R52.2

ICD-10 Finland

Other chronic pain

20.0

54.9

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

5.7

52.2

173

407

N06AX11

ATC

mirtazapine; oral

4.0

50.1

280

1112

X59

ICD-10 Finland

Exposure to unspecified factor

4.7

47.1

195

576

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

13.5

47.0

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

24.8

46.6

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

9.4

46.1

100

126

G54.0

ICD-10 Finland

Brachial plexus disorders

44.2

45.7

N03AE01

ATC

clonazepam; systemic

9.3

45.7

100

128

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

4.0

45.0

239

885

M25.5

ICD-10 Finland

Pain in joint

3.9

44.7

249

961

N06AX16

ATC

venlafaxine; oral

4.9

44.6

171

463

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

104.8

44.5

Z01.8

ICD-10 Finland

Other specified special examinations

4.1

43.1

208

702

N03AX09

ATC

lamotrigine; oral

8.7

42.8

131

R52.1

ICD-10 Finland

Chronic intractable pain

74.7

42.8

G56.2

ICD-10 Finland

Lesion of ulnar nerve

46.6

42.1

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

3.4

41.6

346

1801

AEA24

NOMESCO Finland

Removal of spinal stimulation elecrode

226.6

41.5

N07BC02

ATC

methadone; systemic

+∞

40.1

WX408

NOMESCO Finland

General anesthesy, balanced

3.6

38.6

229

903

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

6.5

38.6

108

198

X58

ICD-10 Finland

Exposure to other specified factors

4.7

38.6

151

410

TAC99

NOMESCO Finland

Other blockade for chronic pain

110.4

38.3

ABD99

NOMESCO Finland

Other operation on spinal cord or nerve for pain or impaired function

+∞

36.9

M54.4

ICD-10 Finland

Lumbago with sciatica

4.1

35.4

163

512

TPH04

NOMESCO Finland

Cathetrisation of vein

3.9

35.4

177

599

A01

ICPC

Pain general/multiple sites

6.6

35.2

173

N06AA10

ATC

nortriptyline; systemic

17.2

35.1

WX704

NOMESCO Finland

Intubation

6.1

34.4

101

196

ND1AA

NOMESCO Finland

Wrist X-ray examination

7.4

34.0

132

M54.5

ICD-10 Finland

Low back pain

3.2

33.9

251

1142

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

7.7

31.7

114

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

5.1

31.3

107

247

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

3.0

31.1

269

1337

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

5.3

31.0

103

230

S18

ICPC

Laceration/cut

2.9

30.7

273

1378

R51.80

ICD-10 Finland

Headache

4.0

30.3

140

434

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

25.1

30.1

M03BX01

ATC

baclofen; systemic

21.6

30.1

N02BE01

ATC

paracetamol; systemic, rectal

4.5

29.9

512

3972

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

4.8

29.9

109

269

A02BC05

ATC

esomeprazole; systemic

2.8

29.4

283

1489

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

4.5

29.2

115

306

WX725

NOMESCO Finland

Noninvasive ventilation

7.9

29.2

SPAT1153

SPAT

Removal of sutures

3.0

28.7

218

982

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.8

28.5

272

1415

N05AH04

ATC

quetiapine; oral

3.6

28.3

152

532

AA1AD

NOMESCO Finland

CT of head and brain

3.4

27.9

165

618

N02AJ06

ATC

codeine and paracetamol; systemic

2.8

27.9

269

1400

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

5.9

27.8

158

R52.9

ICD-10 Finland

Pain, unspecified

5.3

27.6

196

WX702

NOMESCO Finland

Supraglottic ventilation device

6.7

27.4

123

M48.0

ICD-10 Finland

Spinal stenosis

5.1

27.1

204

L12

ICPC

Hand/finger symptom/complaint

4.0

27.1

119

350

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

13.0

27.0

W00

ICD-10 Finland

Fall on same level involving ice and snow

4.3

26.9

109

297

M03BC01

ATC

orphenadrine (citrate); systemic

2.9

25.6

192

843

A02BC03

ATC

lansoprazole; oral

2.9

25.5

202

920

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

4.8

25.5

213

3544A

ICD-9 Finland

Mononeuritis of upper limb and mononeuritis multiplex, Causalgia of upper limb

+∞

25.2

ACC53

NOMESCO Finland

Release of ulnar nerve

+∞

25.2

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

5.4

25.1

169

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

9.2

24.9

H02AB06

ATC

prednisolone; systemic

2.6

24.9

298

1722

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5.3

24.7

172

N03AF01

ATC

carbamazepine; oral, rectal

6.7

24.3

106

AEA20

NOMESCO Finland

Removal of impulse generator of stimulation device in the nervous system

+∞

24.1

M54.1

ICD-10 Finland

Radiculopathy

9.4

23.9

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

25.0

23.7

WX720

NOMESCO Finland

Own respiration

7.4

23.5

M19.0

ICD-10 Finland

Primary arthrosis of other joints

4.7

23.2

198

N03AF02

ATC

oxcarbazepine; oral

8.8

23.0

J01FF01

ATC

clindamycin; systemic

2.7

22.8

198

940

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.6

22.8

114

371

WX002

NOMESCO Finland

Sedation and analgesia

3.1

22.3

145

572

ZXA00

NOMESCO Finland

Right side

2.9

22.1

167

726

M03BX02

ATC

tizanidine; oral

2.5

22.0

401

2816

W19

ICD-10 Finland

Unspecified fall

4.5

21.7

207

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

6.2

21.4

104

S06.0

ICD-10 Finland

Concussion

3.8

21.0

283

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

11.0

21.0

M01AH05

ATC

etoricoxib; oral

2.4

21.0

377

2592

R4120

NOMESCO Finland

Occupational therapy

5.6

20.9

124

A06AD11

ATC

lactulose; oral

3.9

20.9

273

2402

FHL

External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)

79.9

20.8

TAC00

NOMESCO Finland

Peripheral nerve block

79.9

20.8

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

43.4

20.6

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.6

20.6

185

887

A02BC01

ATC

omeprazole; systemic

2.6

20.6

187

902

R07.4

ICD-10 Finland

Chest pain, unspecified

2.7

20.5

169

770

M54.9

ICD-10 Finland

Dorsalgia, unspecified

3.7

20.5

300

L86

ICPC

Back syndrome with radiating pain

6.2

20.2

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.1

20.1

227

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.7

20.1

171

792

M01AE03

ATC

ketoprofen; systemic, rectal

2.4

20.1

247

1395

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

4.1

19.9

224

TAD02

NOMESCO Finland

Sympathetic block of ganglion stellatum

+∞

19.9

N02AC04

ATC

dextropropoxyphene; oral

9.0

19.8

NDA30

NOMESCO Finland

Exploration of joint of wrist or hand, arthroscopic

25.7

19.7

N05BA01

ATC

diazepam; systemic, rectal

3.4

19.6

106

361

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.9

19.6

243

A02BC02

ATC

pantoprazole; systemic

2.3

19.6

379

2652

M01AX01

ATC

nabumetone; oral

7.9

19.6

N29

ICPC

Neurological sympt/complt other

14.0

19.5

ZXD05

NOMESCO Finland

Urgent procedure

2.4

19.4

214

1138

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

5.4

19.4

122

L11

ICPC

Wrist symptom/complaint

4.5

19.3

179

L28

ICPC

Limited function/disability (L)

3.5

19.1

328

M79.0

ICD-10 Finland

Rheumatism, unspecified

6.6

19.1

L17

ICPC

Foot/toe symptom/complaint

2.7

19.0

162

745

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

7.7

18.9

AEA27

NOMESCO Finland

Replacement of spinal stimulation electrode

+∞

18.9

L03

ICPC

Low back symptom/complaint

2.6

18.8

166

782

M79.7

ICD-10 Finland

Fibromyalgia

7.2

18.7

XA402

NOMESCO Finland

ENMG

12.0

18.7

M54.2

ICD-10 Finland

Cervicalgia

4.6

18.7

160

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

5.9

18.7

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

10.1

18.7

NA1AD

NOMESCO Finland

Cervical spine CT examination

7.1

18.3

M53.1

ICD-10 Finland

Cervicobrachial syndrome

3.5

18.2

299

WX120

NOMESCO Finland

Intravenous local anesthesy of arm

16.0

18.2

ZXA05

NOMESCO Finland

Left side

2.6

18.1

155

712

M75.1

ICD-10 Finland

Rotator cuff syndrome

2.6

18.1

157

726

C03CA01

ATC

furosemide; systemic

2.8

18.0

134

566

J01DA01

ATC

[U] cefalexin; systemic

2.2

17.8

383

2751

R03AC02

ATC

salbutamol; inhalant

2.2

17.8

329

2208

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

3.3

17.7

340

R06.0

ICD-10 Finland

Dyspnoea

2.6

17.6

151

695

SPAT1301

SPAT

No procedures

2.4

17.6

189

982

SPAT1263

SPAT

Sampling

2.2

17.4

267

1639

M54.3

ICD-10 Finland

Sciatica

4.9

17.4

128

R02

ICPC

Shortness of breath/dyspnoea

3.5

17.3

281

WX110

NOMESCO Finland

Local anesthesy

2.3

17.1

421

3186

ZXE20

NOMESCO Finland

More than three and less than five hours

3.1

17.0

100

362

M01AH02

ATC

rofecoxib; oral

3.3

17.0

326

M01AB05

ATC

diclofenac; systemic, rectal

2.2

16.9

402

2983

NH1AD

NOMESCO Finland

Ankle and foot CT

8.1

16.9

A28

ICPC

Limited function/disability NOS

3.5

16.7

265

M01AH01

ATC

celecoxib; oral (coxibs)

2.8

16.6

124

522

G44.2

ICD-10 Finland

Tension-type headache

3.0

16.5

104

393

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

5.6

16.5

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.6

16.4

235

L09

ICPC

Arm symptom/complaint

5.9

16.3

S63.3

ICD-10 Finland

Traumatic rupture of ligament of wrist and carpus

12.2

16.2

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

4.4

16.2

148

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

4.2

16.2

163

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

25.4

16.1

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

49.0

16.1

WX400

NOMESCO Finland

Inhalation anesthesy

4.8

16.0

121

D07AC01

ATC

betamethasone; topical

2.2

15.9

208

1175

S52.5

ICD-10 Finland

Fracture of lower end of radius

3.5

15.9

241

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.7

15.8

214

J01AA02

ATC

doxycycline; systemic

2.4

15.8

455

3623

L16

ICPC

Ankle symptom/complaint

3.5

15.8

254

R55

ICD-10 Finland

Syncope and collapse

3.7

15.7

216

A02BA02

ATC

ranitidine; systemic

2.7

15.6

121

520

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.9

15.6

106

420

M47.9

ICD-10 Finland

Spondylosis, unspecified

8.3

15.5

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

8.3

15.5

N05CF01

ATC

zopiclone; oral

2.3

15.5

185

997

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

7.0

15.4

L08

ICPC

Shoulder symptom/complaint

2.6

15.3

122

533

R42

ICD-10 Finland

Dizziness and giddiness

2.6

15.1

131

599

N06AA12

ATC

doxepin; systemic

5.0

15.0

106

M77.1

ICD-10 Finland

Lateral epicondylitis

3.9

15.0

180

L29

ICPC

Musculoskeletal sympt/complt other

4.1

14.9

155

G56.3

ICD-10 Finland

Lesion of radial nerve

58.3

14.9

G57.3

ICD-10 Finland

Lesion of lateral popliteal nerve

58.3

14.9

Z3226

NOMESCO Finland

Physiotherapist

2.6

14.8

125

564

M01AE02

ATC

naproxen; oral, rectal

2.0

14.7

341

2426

J01DB01

ATC

cefalexin; oral

2.5

14.7

478

3941

WX204

NOMESCO Finland

Axillary plexus blockaced

6.5

14.7

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

3.2

14.6

279

J01MA02

ATC

ciprofloxacin; systemic

2.1

14.6

221

1317

WZB00

NOMESCO Finland

Telephone receipt or other advice

2.2

14.4

197

1126

SPAT1229

SPAT

Assessment of need for aid

4.2

14.4

145

S93.4

ICD-10 Finland

Sprain and strain of ankle

3.1

14.4

290

F43.1

ICD-10 Finland

Post-traumatic stress disorder

6.5

14.4

WX290

NOMESCO Finland

Other blockade of nerve

2.0

14.3

287

1917

M02AA07

ATC

piroxicam; topical

2.1

14.3

213

1261

Z50.1

ICD-10 Finland

Other physical therapy

5.0

14.2

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

5.3

14.1

R1250

NOMESCO Finland

Evaluation of functional capability

9.2

14.1

R50.9

ICD-10 Finland

Fever, unspecified

2.9

14.1

363

G50.1

ICD-10 Finland

Atypical facial pain

16.3

14.0

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

2.0

14.0

306

2110

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.0

14.0

325

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

4.7

14.0

110

R33

ICD-10 Finland

Retention of urine

4.8

13.8

102

L15

ICPC

Knee symptom/complaint

2.4

13.7

132

636

B01AB05

ATC

enoxaparin; parenteral

2.2

13.7

177

979

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

4.6

13.5

109

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

4.0

13.4

144

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

7.6

13.4

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

4.8

13.4

101

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

4.0

13.3

145

SPAT1284

SPAT

Extensive health certificate

7.9

13.3

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

5.1

13.3

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

8.2

13.2

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.1

13.2

206

1233

M01AX17

ATC

nimesulide; oral

2.3

13.1

145

746

J45.9

ICD-10 Finland

Asthma, unspecified

2.5

13.1

112

505

NG4AA

NOMESCO Finland

Lower leg X-ray examination

5.9

13.1

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

29.1

13.0

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.0

12.9

243

1564

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

5.2

12.9

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.8

12.8

357

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

7.3

12.7

TQW40

NOMESCO Finland

Remowal of suture of skin

3.5

12.7

184

R52.0

ICD-10 Finland

Acute pain

5.4

12.7

M65.3

ICD-10 Finland

Trigger finger

5.7

12.6

G56.1

ICD-10 Finland

Other lesions of median nerve

+∞

12.5

G56.8

ICD-10 Finland

Other mononeuropathies of upper limb

+∞

12.5

ND1CG

NOMESCO Finland

Wrist and hand extensive MRI examination with high intensity magnet

13.6

12.5

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

3.9

12.4

144

R06AE07

ATC

cetirizine; oral

1.9

12.4

271

1839

M24.2

ICD-10 Finland

Disorder of ligament

10.8

12.4

JAH01

NOMESCO Finland

Laparoscopy

4.1

12.3

125

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.4

12.3

112

522

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

8.0

12.3

T92.2

ICD-10 Finland

Sequelae of fracture at wrist and hand level

16.3

12.2

A03FA01

ATC

metoclopramide; systemic, rectal

2.3

12.2

131

662

N06AB04

ATC

citalopram; systemic

2.2

12.2

139

724

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.4

12.2

112

526

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.1

12.1

249

T93.2

ICD-10 Finland

Sequelae of other fractures of lower limb

11.4

12.1

C07AB07

ATC

bisoprolol; oral

2.0

12.1

224

1423

EBA00

NOMESCO Finland

Extraction of tooth

2.0

12.1

195

1172

T92.3

ICD-10 Finland

Sequelae of dislocation, sprain and strain of upper limb

27.4

12.1

Z04.3

ICD-10 Finland

Examination and observation following other accident

7.8

12.0

L99

ICPC

Musculoskeletal disease other

8.7

11.9

M18.1

ICD-10 Finland

Other primary arthrosis of first carpometacarpal joint

10.9

11.9

C01DA14

ATC

isosorbide mononitrate; oral

3.5

11.8

173

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

8.0

11.8

M01AH03

ATC

valdecoxib; oral

3.5

11.7

168

G56.9

ICD-10 Finland

Mononeuropathy of upper limb, unspecified

66.4

11.6

NH1FA

NOMESCO Finland

Weight-bearing X-ray of ankle

19.4

11.6

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

23.5

11.6

R20.2

ICD-10 Finland

Paraesthesia of skin

3.4

11.6

175

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

5.3

11.6

K07.60

ICD-10 Finland

Snapping jaw

4.0

11.6

122

SPAT1097

SPAT

Recording of ECG

2.7

11.5

353

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.1

11.5

158

889

N02AA03

ATC

hydromorphone; systemic, rectal

+∞

11.5

P29

ICPC

Psychological sympt/compl other

4.0

11.5

123

N05CF02

ATC

zolpidem; oral

2.2

11.4

126

641

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.6

11.4

155

N01

ICPC

Headache

2.8

11.4

285

RF210

NOMESCO Finland

5.7

11.4

XA800

NOMESCO Finland

Neuropsychological investigation

4.8

11.3

N06AB06

ATC

sertraline; oral

2.7

11.3

335

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.7

11.2

141

NDG60

NOMESCO Finland

Arthroplasty of first CMC joint

13.1

11.2

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.1

11.2

138

740

SPAT1210

SPAT

Application of cast or individual aid

5.0

11.2

G50.0

ICD-10 Finland

Trigeminal neuralgia

20.5

11.2

J01DA09

ATC

[U] cefadroxil; inhalant, oral

2.0

11.1

166

963

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.0

11.0

171

1008

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.8

11.0

327

2426

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

5.9

11.0

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

6.7

10.9

G57.6

ICD-10 Finland

Lesion of plantar nerve

12.2

10.9

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

4.1

10.8

109

J01FA10

ATC

azithromycin; systemic

1.8

10.8

351

2675

G83.4

ICD-10 Finland

Cauda equina syndrome

28.6

10.8

ZXD20

NOMESCO Finland

Day surgery

2.5

10.7

408

M79.1

ICD-10 Finland

Myalgia

2.5

10.7

388

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

3.7

10.6

137

S01

ICPC

Pain/tenderness of skin

4.6

10.6

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

8.8

10.6

ND1BG

NOMESCO Finland

Wrist and hand MRI examination with high intensity magnet

11.5

10.6

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

7.5

10.6

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.8

10.6

122

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.8

10.5

300

2179

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.7

10.5

305

T92.4

ICD-10 Finland

Sequelae of injury of nerve of upper limb

+∞

10.4

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

5.5

10.4

SPAT1254

SPAT

Administration of medicine

2.5

10.4

358

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

3.6

10.3

135

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

23.9

10.3

N05AA02

ATC

levomepromazine; systemic

4.3

10.3

UJF32

NOMESCO Finland

Coloscopy

2.1

10.2

142

796

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

4.0

10.2

105

M70.6

ICD-10 Finland

Trochanteric bursitis

2.7

10.2

304

W22

ICD-10 Finland

Striking against or struck by other object(s)

3.5

10.2

142

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.8

10.1

116

N05BA04

ATC

oxazepam; oral

2.0

10.1

148

846

N06AX26

ATC

vortioxetine; oral

3.4

10.1

154

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

3.2

10.1

171

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

5.7

10.1

SAA01

NOMESCO Finland

Simple examination of mouth

1.9

10.0

407

3299

K59.0

ICD-10 Finland

Constipation

4.1

10.0

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.6

10.0

312

N05CD07

ATC

temazepam; oral

2.7

10.0

275

SPAT1058

SPAT

PEF monitoring instruction

3.0

10.0

208

TPH07

NOMESCO Finland

Cathetrisation of artery

2.9

9.9

233

R96

ICPC

Asthma

2.9

9.8

220

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

20.5

9.8

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.6

9.8

130

SPAT1262

SPAT

Handing over of treatment supplies

2.3

9.8

101

496

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.8

9.8

235

N02AJ13

ATC

tramadol and paracetamol; systemic

7.6

9.8

R09

ICPC

Sinus symptom/complaint

3.0

9.8

211

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

7.0

9.7

WX203

NOMESCO Finland

Infraclavicular plexus blockade

7.0

9.7

XFE00

NOMESCO Finland

Epicardial ultrasonography

7.3

9.6

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

9.3

9.6

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.7

9.6

280

M01AC06

ATC

meloxicam; systemic, rectal

1.8

9.4

205

1349

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

3.9

9.4

103

Z3229

NOMESCO Finland

Other healthcare associate professional

3.0

9.4

198

3540A

ICD-9 Finland

Mononeuritis of upper limb and mononeuritis multiplex, Carpal tunnel syndrome

+∞

9.4

ACC52

NOMESCO Finland

Release of radial nerve

+∞

9.4

SPAT1240

SPAT

Therapeutic discussion

2.5

9.4

325

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.5

9.4

338

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

6.6

9.3

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

10.9

9.3

A06AC01

ATC

ispaghula (psylla seeds); oral

2.0

9.3

134

760

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5.6

9.3

WX200

NOMESCO Finland

Interscalenous plexus blockade

7.5

9.3

J45.1

ICD-10 Finland

Nonallergic asthma

3.2

9.3

159

TAB20

NOMESCO Finland

Epidural puncture

14.0

9.2

EBA05

NOMESCO Finland

Complicated extraction of tooth

2.1

9.2

121

663

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

6.4

9.2

D07AD01

ATC

clobetasol; topical

2.2

9.1

469

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.1

9.1

107

559

UKC02

NOMESCO Finland

Cystoscopy

2.4

9.1

338

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.3

9.1

398

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.6

9.1

278

WX308

NOMESCO Finland

Sacral anesthesy

37.3

9.0

Y86

ICD-10 Finland

Sequelae of other accidents

37.3

9.0

L14

ICPC

Leg/thigh symptom/complaint

3.1

9.0

178

SAA04

NOMESCO Finland

Special inverstigation of mouth

3.3

9.0

145

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

7.6

9.0

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

7.6

9.0

TAB00

NOMESCO Finland

Lumbar puncture

3.6

9.0

113

N06AX03

ATC

mianserin; oral

3.7

8.9

108

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

3.2

8.9

152

JN3AD

NOMESCO Finland

Abdominal CT examination

3.1

8.9

173

K04.1

ICD-10 Finland

Necrosis of pulp

2.5

8.9

301

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.4

8.8

131

SAA03

NOMESCO Finland

Extended examination of mouth

1.8

8.8

226

1561

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

2.3

8.8

385

R03DC03

ATC

montelukast; oral

2.1

8.8

105

551

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.5

8.8

289

L04

ICPC

Chest symptom/complaint

3.4

8.8

126

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

4.5

8.7

R03AC12

ATC

salmeterol; inhalant

4.5

8.7

M19.8

ICD-10 Finland

Other specified arthrosis

5.2

8.7

N03A

ATC

ANTIEPILEPTICS

50.8

8.7

C02AC01

ATC

clonidine; systemic

50.8

8.7

N06AB10

ATC

escitalopram; oral

2.0

8.6

130

749

NC2AA

NOMESCO Finland

Forearm X-ray examination

10.3

8.6

R51.81

ICD-10 Finland

Facial pain NOS

5.5

8.5

M96.0

ICD-10 Finland

Pseudarthrosis after fusion or arthrodesis

28.0

8.5

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

4.6

8.5

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.5

8.4

290

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

6.9

8.4

M25.2

ICD-10 Finland

Flail joint

8.0

8.4

C07AB02

ATC

metoprolol; systemic

2.2

8.4

463

NDM20

NOMESCO Finland

Excision of synovial ganglion of wrist or hand

5.4

8.4

S63.6

ICD-10 Finland

Sprain and strain of finger(s)

4.1

8.4

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.8

8.4

201

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

+∞

8.4

NCK30

NOMESCO Finland

Angulation, rotation or displacement osteotomy of elbow or forearm, other location

+∞

8.4

T91.8

ICD-10 Finland

Sequelae of other specified injuries of neck and trunk

+∞

8.4

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

+∞

8.4

AXX90

NOMESCO Finland

Intravascular test of medication against pain

+∞

8.4

N81

ICPC

Injury nervous system other

+∞

8.4

W10

ICD-10 Finland

Fall on and from stairs and steps

3.5

8.3

115

-1

NOMESCO Finland

1.8

8.3

201

1354

C10AA01

ATC

simvastatin; oral

1.8

8.3

171

1098

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

3.5

8.3

110

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.1

8.3

103

549

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.4

8.3

311

M50.3

ICD-10 Finland

Other cervical disc degeneration

6.6

8.2

M77.0

ICD-10 Finland

Medial epicondylitis

5.5

8.2

L81

ICPC

Injury musculoskeletal NOS

7.7

8.2

WZA90

NOMESCO Finland

Other doctors statement

1.9

8.2

132

776

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

2.3

8.2

360

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

5.0

8.2

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.6

8.1

243

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3047181) Lactate [Moles/volume] in Blood

119

7.87

56.40

5.3

11.3

mmol/l

1.1

1.3

0.86

106

(3039000) Anion gap in Blood

7.61

41.83

5.7

13.1

mmol/l

10.8

11.5

0.94

(3018572) Chloride [Moles/volume] in Blood

7.61

41.83

5.8

13.1

mmol/l

104.9

105.1

0.13

(3032080) INR in Blood by Coagulation assay

331

1695

2.99

40.36

9.0

7.3

inr

1.2

1.1

0.65

539

(3013826) Glucose [Moles/volume] in Serum or Plasma

448

2768

3.11

37.70

5.7

4.5

mmol/l

6.6

6.5

0.43

428

2555

(3008152) Bicarbonate [Moles/volume] in Arterial blood

226

4.71

36.91

6.9

10.5

mmol/l

25.4

24.7

1.19

213

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

271

1304

2.88

36.13

2.4

2.0

u/l

166.7

229.0

0.55

258

1231

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

206

4.80

35.66

6.9

14.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

384

2230

2.83

35.41

7.2

6.5

mmol/l

1.2

0.63

333

1876

(3024561) Albumin [Mass/volume] in Serum or Plasma

347

1923

2.78

34.90

5.7

4.8

g/l

36.2

0.02

320

1811

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

350

1987

2.70

32.94

5.4

5.7

mmol/l

1.2

0.34

318

1802

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

193

826

2.92

31.29

4.3

3.2

ng/l

50.6

254.6

2.92

132

572

(3019060) Gas panel - Arterial blood

239

4.22

30.93

5.5

7.4

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

285

1507

2.62

30.34

3.7

2.4

u/l

50.9

56.2

1.61

263

1401

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

162

4.81

29.54

5.2

8.8

1.9

1.7

0.74

154

(3013707) Erythrocyte sedimentation rate by Westergren method

520

3755

3.14

28.35

4.9

3.7

mm/h

11.0

10.5

0.46

498

3480

(3007930) Methemoglobin/Hemoglobin.total in Blood

159

4.75

28.34

5.5

8.9

1.0

0.9

0.88

152

(3016502) Oxygen saturation in Arterial blood

109

376

3.29

25.28

7.1

11.0

96.6

96.1

0.55

102

365

(42870588) Differential panel, method unspecified - Blood

283

1605

2.38

24.57

5.1

5.6

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

105

363

3.27

24.22

7.3

11.2

g/l

126.6

121.8

1.44

353

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

116

429

3.09

23.86

6.9

10.2

kpa

5.2

5.1

0.18

110

413

(3027801) Oxygen [Partial pressure] in Arterial blood

116

429

3.09

23.86

6.9

10.2

kpa

11.8

12.6

1.31

110

414

(3003396) Base excess in Arterial blood by calculation

116

430

3.08

23.76

7.0

10.1

mmol/l

2.1

1.2

1.84

341

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

385

2518

2.35

23.66

5.1

6.3

umol/l

9.8

10.6

0.69

356

2399

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

518

3879

2.83

23.54

7.8

7.1

u/l

75.2

76.3

0.32

497

3655

(3019150) Specific gravity of Urine by Refractometry

208

1050

2.46

23.21

4.6

3.3

kg/l

1.0

0.23

125

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

217

1143

2.37

21.79

2.0

1.7

mg/l

0.9

1.0

0.59

169

872

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

293

1751

2.25

21.79

3.5

3.3

u/l

32.9

30.8

0.14

283

1662

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

360

2350

2.23

21.39

4.9

3.8

—

(3042936) Bacteria identified in Isolate by Culture

143

630

2.64

21.03

2.6

2.0

—

(3007853) Bacteria identified in Skin by Aerobe culture

125

515

2.78

20.96

2.0

1.5

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

148

666

2.59

20.82

1.9

1.8

—

(3031040) Bacteria [#/volume] in Urine by Automated count

445

3237

2.26

19.28

5.7

3.8

e6/l

68.1

887.5

—

(3026008) Bacteria identified in Urine by Culture

233

1325

2.20

18.99

4.1

2.6

—

(3037522) Nuclear Ab [Titer] in Serum

150

708

2.47

18.91

1.4

1.3

titre

483.3

532.1

0.13

139

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

275

1672

2.14

18.86

3.9

3.0

ng/l

22.2

34.3

1.25

166

1008

(3037467) Urinalysis macro (dipstick) panel - Urine

465

3467

2.28

18.61

5.8

3.8

—

(3018418) pH of Serum or Plasma

232

1340

2.15

17.98

3.1

3.8

7.4

0.10

253

(3019309) Folate [Moles/volume] in Red Blood Cells

143

692

2.38

16.89

2.0

1.6

nmol/l

1123.7

1221.9

0.75

111

522

(3023368) Bacteria identified in Blood by Culture

200

1114

2.16

16.82

4.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

282

1794

2.03

16.54

2.3

1.8

pmol/l

100.3

95.9

0.82

146

889

(3006315) Basophils [#/volume] in Blood

364

2536

2.02

16.50

5.7

5.5

e9/l

0.0

1.91

325

2225

(3006504) Eosinophils/100 leukocytes in Blood

346

2374

2.01

16.31

5.6

5.7

2.9

2.8

0.38

323

2212

(3018677) aPTT in Platelet poor plasma by Coagulation assay

138

667

2.37

16.29

1.9

2.0

28.4

29.6

1.65

125

651

(3019069) Monocytes/100 leukocytes in Blood

347

2385

2.00

16.25

5.9

8.3

8.4

0.10

327

2240

(3013115) Eosinophils [#/volume] in Blood

372

2623

2.01

16.17

5.8

5.9

e9/l

0.2

2.17

338

2333

(3001604) Monocytes [#/volume] in Blood

361

2526

2.00

15.95

5.7

5.5

e9/l

0.6

0.01

322

2217

(3022096) Basophils/100 leukocytes in Blood

334

2293

1.96

15.40

5.7

0.7

0.01

312

2137

(3009508) Creatinine [Moles/volume] in Urine

229

1397

2.00

14.72

3.6

3.0

mmol/l

7.7

0.04

205

1194

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

168

923

2.12

14.32

1.4

1.3

iu/ml

18.2

29.9

0.75

302

(3019198) Lymphocytes [#/volume] in Blood

363

2602

1.92

14.32

5.7

5.5

e9/l

2.0

1.9

0.97

330

2323

(3018010) Neutrophils/100 leukocytes in Blood

345

2435

1.91

14.23

5.8

5.5

54.5

57.0

4.21

324

2286

(3019550) Sodium [Moles/volume] in Serum or Plasma

610

5397

4.44

13.67

20.3

12.5

mmol/l

139.6

139.7

0.81

605

5256

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

166

924

2.08

13.59

1.6

pmol/l

233557473.4

14543545.7

1.05

149

777

(3023103) Potassium [Moles/volume] in Serum or Plasma

611

5417

4.53

13.54

20.3

12.5

mmol/l

4.0

3.9

1.42

605

5260

(3002030) Lymphocytes/100 leukocytes in Blood

345

2460

1.88

13.54

5.8

5.7

31.1

28.6

4.74

325

2302

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

102

466

2.42

13.51

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

100

456

2.42

13.29

1.8

1.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

5.38

12.58

1.9

1.5

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

447

2.38

12.56

2.3

2.0

nmol/l

353.1

366.2

0.27

417

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

179

1057

1.97

12.27

2.3

2.9

ng/l

680.3

784.5

0.23

146

882

(3012516) Albumin [Mass/volume] in Urine

202

1249

1.91

12.03

3.5

3.1

mg/l

1753.3

339.4

1.18

135

793

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

503

4138

2.04

11.95

5.1

4.0

pmol/l

14.4

14.6

1.42

471

3804

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

184

1109

1.93

11.81

2.4

2.0

mg/l

2.4

2.9

2.76

169

956

(3012095) Magnesium [Moles/volume] in Serum or Plasma

133

718

2.08

11.64

2.8

3.5

mmol/l

0.8

0.19

121

676

(3027923) C peptide [Moles/volume] in Serum or Plasma

6.83

11.52

1.3

1.7

nmol/l

1.2

1.1

0.11

(3013650) Neutrophils [#/volume] in Blood by Automated count

390

2976

1.81

11.47

7.8

9.0

e9/l

4.0

0.05

352

2620

(36660697) Celiac disease serology panel - Serum

402

2.32

10.73

1.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

165

989

1.90

10.62

1.5

1.4

nmol/l

20.9

21.3

0.14

147

848

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

594

5302

2.91

10.46

19.0

11.4

mg/l

18.8

22.1

2.26

528

4058

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

4.06

10.41

1.3

1.4

—

(3011288) Drugs identified in Urine by Screen method

161

3.00

10.24

3.7

2.1

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

290

2082

1.72

10.08

2.8

2.2

nmol/l

74.0

76.1

0.61

268

1911

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

150

886

1.91

10.03

1.4

1.2

u/ml

4.1

13.6

2.00

382

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

120

3.30

10.03

1.3

2.2

g/l

9.6

10.2

0.34

110

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

132

3.17

9.83

1.3

2.1

g/l

7.3

7.4

0.17

104

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

132

3.17

9.83

1.3

2.1

g/l

3.6

3.9

0.98

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

132

3.17

9.83

1.3

2.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

122

3.25

9.77

1.2

2.2

g/l

2.9

3.1

0.49

101

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

105

3.36

9.30

1.2

mmol/l

3.9

3.7

0.41

(3020682) Albumin/Creatinine [Ratio] in Urine

199

1323

1.73

8.88

4.2

3.8

mg/mmol

11.1

9.4

0.20

130

832

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

187

1222

1.75

8.86

1.3

1.2

u/ml

1.1

1.9

0.97

350

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

100

3.32

8.60

1.7

1.4

—

(3015736) pH of Urine

266

1928

1.65

8.50

3.9

2.9

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

452

3753

1.71

8.42

3.9

2.9

u/l

53.9

43.3

1.44

428

3549

(3044290) Cell count panel - Cerebral spinal fluid

3.37

8.31

1.3

1.6

—

(3023520) Reticulocytes [#/volume] in Blood

294

2.31

8.29

2.2

2.7

e9/l

72.2

73.8

0.13

224

(3020630) Protein [Mass/volume] in Serum or Plasma

302

2.28

8.20

1.4

2.3

g/l

66.9

67.8

0.53

283

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

105

3.16

7.96

1.2

1.5

e6/l

4.2

3.6

0.10

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

105

3.16

7.96

1.3

1.6

e6/l

760.5

1148.8

0.13

(1761868) Lipid panel - Serum or Plasma

151

2229

0.58

7.92

2.6

2.5

—

(3044889) 12 lead EKG panel

433

3581

1.66

7.91

4.1

3.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

100

556

1.95

7.89

6.4

5.8

mmol/l

1.1

1.0

1.52

514

(3004588) Protein electrophoresis panel - Serum or Plasma

244

2.37

7.71

1.4

2.1

—

(3000494) Fungus identified in Specimen by Culture

103

584

1.91

7.66

1.6

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

234

2.38

7.51

1.9

1.8

—

(3022948) Iron [Moles/volume] in Serum or Plasma

110

643

1.86

7.44

2.8

2.3

umol/l

12.5

14.0

1.40

101

602

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

548

1.91

7.28

2.4

2.7

umol/l

6.0

6.6

0.14

479

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

4.66

6.96

1.1

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

101

592

1.84

6.75

2.7

2.3

g/l

2.6

2.4

1.65

560

(3015377) Calcium [Moles/volume] in Serum or Plasma

221

1603

1.58

6.66

2.7

3.4

mmol/l

2.3

2.4

1.72

198

1437

(3026493) Urate [Moles/volume] in Serum or Plasma

175

1200

1.63

6.66

2.3

2.4

umol/l

316.0

5909.6

4.26

158

1066

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

546

4893

1.83

6.54

6.3

4.6

mu/l

1.7

2.1

0.80

515

4538

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

538

1.85

6.47

2.7

2.4

22.4

23.7

0.35

471

(4010399)

334

2.05

6.38

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

349

2.03

6.34

3.1

3.7

pmol/l

4.4

4.6

1.02

308

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

540

4836

1.79

6.31

6.2

4.8

mmol/mol

40.0

38.8

2.10

512

4542

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

3.91

6.30

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

4.75

6.24

1.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

258

1966

1.53

6.12

4.5

3.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

197

2.33

6.07

2.6

1.6

—

(3017732) Neutrophils [#/volume] in Blood

348

2.00

6.04

2.3

2.8

e9/l

3.8

4.2

0.85

288

(3035350) Ketones [Presence] in Urine by Test strip

313

2491

1.51

6.00

4.3

3.1

estimate

0.0

0.00

469

(40761511) CBC panel - Blood by Automated count

605

5654

2.53

5.96

19.3

10.8

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

167

2.42

5.94

2.2

1.9

—

(3027945) Reticulocytes/100 erythrocytes in Blood

409

1.92

5.92

2.1

2.5

1.7

1.8

0.40

372

(3028707) Methadone [Presence] in Urine by Screen method

2.89

5.90

3.5

1.9

—

(3009261) Glucose [Presence] in Urine by Test strip

317

2539

1.50

5.84

4.3

3.2

estimate

0.0

0.80

457

(3021601) Nitrite [Presence] in Urine by Test strip

314

2511

1.50

5.82

5.9

4.3

estimate

0.0

0.50

474

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

3.98

5.74

1.0

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

3.10

5.70

1.3

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

3.69

5.51

1.6

1.9

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

292

2327

1.47

5.36

3.5

2.7

ug/l

80.4

104.5

2.32

282

2168

(3044941) Cell count panel - Synovial fluid

3.25

5.36

1.4

1.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

3.92

5.29

1.1

1.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

316

1.96

5.18

1.7

1.6

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

3.82

5.11

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

3.82

5.11

1.1

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

3.82

5.11

1.1

1.2

—

(3016879) Cocaine [Presence] in Urine

233

2.10

5.10

2.8

1.5

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

3.47

5.06

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

167

2.29

5.04

1.5

1.9

—

(3019225) pH of Specimen

416

1.82

5.03

4.3

3.5

—

(3044640) Blood type and Crossmatch panel - Blood

206

1547

1.49

5.03

2.6

2.1

—

(40768797) Stomach Pathology biopsy report

105

683

1.64

4.81

1.2

—

(3017704) Immunofixation for Urine

5.06

4.79

1.1

1.7

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

225

2.08

4.78

1.6

2.2

u/l

16491.6

2855.9

—

(3000850) Epithelial cells [#/volume] in Urine

132

911

1.57

4.74

3.7

2.3

e6/l

8.3

6.6

0.48

120

807

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

153

2.29

4.68

1.4

1.2

—

(3008898) HLA-B27 [Presence]

228

2.05

4.63

1.2

1.0

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

135

2.36

4.59

1.5

1.4

ug/g

275.9

324.0

0.49

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.82

4.54

1.0

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

3.65

4.51

1.1

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

3.65

4.51

1.1

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

7.59

4.36

1.4

1.0

nmol/l

248.2

136.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

3.56

4.35

1.4

2.2

—

(3012544) pH of Venous blood

367

1.80

4.30

3.7

3.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

3.09

4.27

1.6

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

3.09

4.27

1.6

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

153

2.22

4.25

1.3

1.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

147

1063

1.50

4.23

1.4

g/l

2.2

2.3

0.47

685

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

2.58

4.17

1.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

161

2.17

4.17

1.5

1.6

iu/ml

0.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

635

0.48

4.17

1.3

1.7

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

3.04

4.15

1.6

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

142

2.24

4.12

1.3

2.1

g/l

1.3

1.5

0.70

125

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

445

0.39

4.10

1.1

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

156

2.18

4.07

2.3

1.7

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

3.57

4.07

1.6

1.2

e6/l

35270.0

165186.7

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

605

5750

2.14

4.06

12.3

9.2

u/l

27.6

26.6

0.72

593

5574

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

2.81

4.05

1.3

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

182

1385

1.44

4.01

2.1

1.6

mmol/l

1.5

1.4

0.81

162

1179

(3022621) pH of Urine by Test strip

293

1.84

3.96

3.2

2.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

557

5174

1.63

3.95

4.8

4.0

mmol/l

6.1

5.8

3.09

529

4789

(4027681)

3.69

3.94

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

2.93

3.92

1.6

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

2.93

3.92

1.6

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

2.93

3.92

1.6

1.4

—

(21494755) Public health laboratory ask at order entry panel

721

0.52

3.90

1.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

3.01

3.87

1.9

1.3

nmol/l

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

147

2.17

3.81

1.1

—

8.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

109

2.35

3.73

4.0

2.6

—

(3033658) Prothrombin time (PT) actual/Normal

162

1223

1.44

3.69

4.1

3.4

98.4

95.7

0.71

157

1189

(3011397) Hemoglobin [Presence] in Urine by Test strip

150

1118

1.45

3.66

4.2

3.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

184

2.01

3.66

2.0

1.7

—

(3027008) Opiates [Presence] in Urine

256

1.86

3.65

2.8

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

104

2.36

3.63

1.5

1.3

—

(3000764) Benzodiazepines [Presence] in Urine

257

1.85

3.61

2.8

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

137

2.17

3.61

2.0

2.1

ug/l

565.5

258.8

0.27

130

(3040151) Glucose [Moles/volume] in Capillary blood

3.14

3.38

1.4

7.0

mmol/l

5.1

7.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

7.06

3.37

1.0

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

108

2.27

3.36

1.3

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

128

2.16

3.34

1.4

1.3

—

(3028300) Cannabinoids [Presence] in Urine

258

1.80

3.27

2.9

1.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

546

1.55

3.21

6.6

6.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

231

1.83

3.16

1.5

1.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

324

1.69

3.10

1.7

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

112

2.19

3.10

1.8

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

168

1.95

3.05

1.5

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

140

2.05

3.05

1.5

1.2

u/ml

2.8

5.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

140

2.05

3.05

1.5

1.2

u/ml

18.1

1.8

—

(3027944) Amphetamines [Presence] in Urine

257

1.77

3.03

2.5

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

108

2.17

2.94

1.6

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

101

728

1.46

2.92

2.1

1.7

1.6

1.4

1.63

647

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

301

0.39

2.88

1.2

1.5

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

6.72

2.87

4.8

7.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

373

1.61

2.82

2.1

2.9

g/l

9.6

10.5

1.02

348

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

430

1.57

2.81

2.4

2.2

g/l

0.2

1.97

407

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

4.49

2.80

1.4

1.0

102.5

134.6

—

(3002032) Base excess in Venous blood by calculation

351

1.62

2.76

3.7

3.4

mmol/l

1.8

2.1

0.24

286

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

8.39

2.75

3.8

8.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

2.46

2.73

1.1

1.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

436

1.55

2.65

1.1

1.2

iu/ml

55.9

144.4

3.03

192

(3015171) Extractable nuclear Ab [Units/volume] in Serum

222

1.76

2.64

1.4

1.2

u/ml

3.0

0.7

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

100

2.14

2.61

1.7

1.2

u/ml

246.4

225.6

0.19

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

156

1.90

2.61

1.9

ug/l

0.3

2.9

0.91

149

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

246

1.71

2.60

3.2

2.7

mmol/l

1.5

1.6

0.07

183

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

3.64

2.58

1.3

2.1

132.2

121.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

4.04

2.57

1.5

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

4.04

2.57

1.5

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

2.30

2.53

1.1

1.6

—

(36304419) Bacteria [Presence] in Urine

154

1223

1.34

2.52

3.9

2.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

2.85

2.48

1.4

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

2.85

2.48

1.3

1.9

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

2.41

2.48

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

3.84

2.47

1.1

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

2.97

2.42

2.9

2.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

413

1.53

2.40

1.8

—

(3048689) Calprotectin [Mass/mass] in Stool

685

1.42

2.40

2.1

2.4

ug/g

228.3

102.5

0.76

540

(40768443) Skin Pathology biopsy report

191

1.77

2.38

1.2

—

(3011436) Histone Ab [Units/volume] in Serum

6.29

2.37

1.2

1.1

—

(3002619) Bacteria identified in Specimen by Culture

6.29

2.37

1.0

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

3.67

2.37

1.4

nmol/l

133.9

158.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.18

2.37

1.1

1.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

117

899

1.37

2.36

4.9

3.5

22.2

21.2

0.30

377

(3021901) Oxygen saturation in Capillary blood

2.29

2.36

1.6

2.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

147

1171

1.33

2.34

2.8

2.0

—

(3018405) Lactate [Moles/volume] in Arterial blood

133

1.92

2.34

5.3

4.7

mmol/l

1.1

1.4

1.59

126

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

155

1.84

2.33

1.5

1.9

iu/l

2.8

5.2

1.56

(3041096) Erythrocytes [Presence] in Urine by Automated

176

1440

1.31

2.32

3.5

2.8

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

188

0.37

2.30

1.0

1.5

—

(3037756) Immunofixation for Serum or Plasma

2.25

2.29

1.3

1.8

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

2.71

2.28

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.71

2.28

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

2.12

2.24

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

5.59

2.21

3.8

7.6

—

(3044927) Protein electrophoresis panel - Urine

2.81

2.21

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

149

0.33

2.17

1.0

1.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

4.32

2.15

1.2

1.6

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

4.32

2.15

1.5

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

4.32

2.15

5.0

4.9

—

(3043409) Potassium [Moles/volume] in Arterial blood

110

1.94

2.08

5.9

4.5

mmol/l

3.7

3.8

0.48

100

(3009542) Hematocrit [Volume Fraction] of Blood

536

5080

1.36

2.06

20.6

12.2

38.5

40.4

3.51

338

3997

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

176

0.39

2.06

1.0

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

176

0.39

2.06

1.0

1.4

—

(44790047)

2.35

2.06

1.2

1.8

—

(44790049)

2.35

2.06

1.2

1.8

—

(44806118)

2.35

2.06

1.2

1.8

—

(44790048)

2.35

2.06

1.2

1.8

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

177

0.39

2.06

1.0

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

177

0.39

2.06

1.0

1.4

—

(3005033) Fetal Nuchal fold Thickness US

145

0.34

2.04

1.0

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

138

1111

1.31

2.03

1.6

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

146

0.34

2.03

1.0

1.4

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

2.25

2.02

1.1

—

(3026782) Osmolality of Urine

111

867

1.34

2.02

3.1

2.5

mosm/kgh2o

507.5

538.3

0.80

748

(3050129) First trimester maternal screen panel - Serum or Plasma

204

0.43

1.98

1.2

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.57

1.94

1.4

1.1

—

(3034988) Calcium [Moles/volume] in Capillary blood

4.57

1.94

1.2

2.3

mmol/l

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

2.47

1.94

2.6

4.1

—

(3020891) Body temperature

150

1.76

1.93

4.8

4.7

—

(3004616) Nuclear Ab [Presence] in Serum

2.27

1.92

1.4

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1.96

1.86

1.9

1.4

u/ml

86.0

110.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

311

1.52

1.86

1.0

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

3.55

1.84

1.3

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

4.19

1.82

1.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

101

1.91

1.82

1.9

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

158

1316

1.27

1.78

4.6

3.5

estimate

0.0

0.69

465

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

136

1112

1.28

1.78

4.1

4.0

ug/l

1.9

2.5

0.80

126

1012

(3002582) Erythrocytes [#/volume] in Urine

162

1356

1.26

1.75

4.2

2.8

e6/l

17.7

118.4

1.32

132

1021

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

742

1.33

1.74

1.7

1.9

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2.94

1.72

3.1

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

3.87

1.72

1.2

1.3

—

(4062490)

2.20

1.68

1.5

1.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1.91

1.66

1.8

2.6

kpa

8.9

8.2

0.88

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

2.82

1.65

2.1

3.1

u/ml

549.9

629.9

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

113

1.79

1.62

1.2

1.8

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

3.59

1.62

6.8

2.3

—

(4024509)

2.52

1.60

1.3

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

2.13

1.56

1.8

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

326

1.44

1.52

1.9

2.3

ug/l

3.3

7.8

3.60

295

(3047007) Chlamydophila sp Ab [Presence] in Serum

1.86

1.47

1.2

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

1.90

1.45

1.3

3.9

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

630

1.31

1.40

1.5

1.7

—

(3021788) Differential panel - Synovial fluid

1.96

1.39

1.3

1.5

—

(3028271) Lactate [Moles/volume] in Capillary blood

2.02

1.39

1.9

2.1

mmol/l

1.7

1.6

0.06

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.89

1.35

1.9

3.1

—

722.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

403

0.66

1.35

1.8

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

489

5105

0.82

1.33

13.3

10.3

ml/min/173m2

88.0

86.0

1.18

388

4158

(3013512) EKG study

152

1301

1.22

1.33

4.0

3.3

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

1.33

0.0

1.3

—

62.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

672

0.74

1.28

2.1

2.6

ug/l

0.7

0.17

407

(3029075) Extractable nuclear Ab panel - Serum

2.79

1.28

1.0

1.1

—

(4035726)

433

0.68

1.28

1.3

1.4

—

(4306422)

1.80

1.28

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

576

1.30

1.28

5.0

3.9

29.9

31.5

0.52

395

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.41

1.24

1.5

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

651

1.28

1.24

1.6

1.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

1.78

1.24

1.3

1.4

mmol/l

7.1

7.4

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

1.98

1.22

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.64

1.22

1.8

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.64

1.22

1.8

1.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.64

1.22

1.2

1.0

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

117

1.64

1.19

1.2

1.8

—

(3018095) Leukocytes [#/volume] in Urine

188

1660

1.19

1.18

4.4

3.3

e6/l

36.9

85.8

1.14

145

1119

(3021879) Hepatitis B virus core Ab [Presence] in Serum

405

1.34

1.17

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

174

1.52

1.17

1.1

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

1.16

0.0

1.5

—

(3000991) Gas panel - Venous blood

327

1.37

1.16

8.3

9.0

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

2.06

1.15

2.3

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

452

1.31

1.13

4.1

3.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

678

1.26

1.12

1.7

1.8

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.35

1.12

1.3

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

2.35

1.12

1.0

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

176

1.50

1.12

1.1

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

176

1.50

1.12

1.1

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

112

1.62

1.10

1.4

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.39

1.09

1.8

1.0

miu/ml

1272.0

1863.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

2.20

1.08

1.4

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

121

0.49

1.06

2.0

1.6

—

(3025941) Bacteria identified in Stool by Culture

315

1.36

1.06

1.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

2.13

1.06

1.1

1.7

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

562

5462

1.25

1.03

5.4

4.4

mmol/l

2.8

2.9

0.59

530

5113

(4198724)

2.28

1.03

2.8

1.5

—

(40767503) Oxygen content in Capillary blood by calculation

1.70

1.02

1.9

2.6

18.8

16.5

—

(3030467) Casts [#/volume] in Urine by Automated count

141

1230

1.19

1.02

4.1

2.8

e6/l

0.5

0.4

0.19

113

901

(3022217) INR in Platelet poor plasma by Coagulation assay

479

1.28

0.99

12.6

16.3

inr

1.1

1.2

—

(40758558) Short blood count panel - Blood

147

1290

1.18

0.99

4.7

6.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

250

1.38

0.98

1.3

1.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1.65

0.98

1.2

1.0

—

13.4

—

(3052851) Hemolysis interference index of Serum or Plasma

124

1.55

0.97

2.9

3.5

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

182

1.45

0.97

2.0

1.5

—

(3022313) Gas panel - Capillary blood

182

1.45

0.97

4.0

2.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

1.81

0.97

1.0

1.2

—

(3021589) Normoblasts [#/volume] in Blood

211

2318

0.87

0.96

8.5

e9/l

0.0

0.15

170

1911

(3022145) Colonoscopy Study observation

564

1.25

0.95

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1.66

0.95

1.6

1.8

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

2.23

0.93

1.7

1.5

—

(40761535) Cells panel - Urine sediment

360

1.30

0.90

3.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

553

5384

1.21

0.87

4.8

4.0

mmol/l

4.8

0.29

526

5068

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

2.01

0.87

1.3

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

124

1086

1.18

0.86

1.8

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.83

0.86

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

141

0.56

0.83

1.5

1.6

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

1.75

0.82

1.1

1.2

—

(3005570) Glucose [Moles/volume] in Urine

1.75

0.82

2.5

2.0

—

(3037121) Protein [Mass/volume] in Urine

138

1.46

0.82

1.8

3.9

g/l

0.4

0.3

—

(3045414) Leukocytes [Presence] in Urine

215

1.37

0.82

1.7

1.8

—

(3000093) Morphology [Interpretation] in Blood Narrative

1.88

0.82

1.0

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

1.71

0.81

1.7

1.9

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

270

0.69

0.80

1.4

—

(3023410) Appearance of Cerebral spinal fluid

1.68

0.79

1.3

2.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

0.77

0.0

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

235

1.34

0.77

2.7

2.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

0.76

0.0

1.1

—

(3022806) Fractional oxyhemoglobin in Capillary blood

1.71

0.75

2.1

2.2

87.6

89.6

—

(3023419) Bacteria identified in Sputum by Culture

1.68

0.74

3.4

2.9

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

2.09

0.74

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

2.09

0.74

1.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.01

0.73

1.2

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.01

0.73

1.2

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.01

0.73

1.2

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.01

0.73

1.2

1.8

—

(4268621)

1.62

0.72

2.2

2.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

1.72

0.70

1.1

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

1.72

0.70

1.1

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

1.72

0.70

1.1

1.8

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.86

0.68

1.0

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

1.67

0.68

1.9

2.0

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

1.73

0.64

1.2

2.8

114.6

102.8

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

1.73

0.64

1.4

2.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

211

0.70

0.63

1.5

1.3

miu/ml

95.8

262.2

—

102

(1761482) Bacteria [#/volume] in Urine by Culture

105

0.57

0.62

1.5

3.7

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1.49

0.61

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

0.00

0.59

0.0

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

0.58

0.0

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

396

3811

1.10

0.57

3.2

—

(3014051) Protein [Presence] in Urine by Test strip

1.44

0.57

1.6

2.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

0.56

4.8

4.7

u/ml

13.6

3252.8

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

450

1.19

0.56

3.1

2.3

u/l

29.2

31.9

0.28

379

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

1.55

0.55

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.63

0.55

1.0

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

547

5365

1.14

0.53

4.6

4.0

mmol/l

1.4

1.5

4.76

520

5031

(3030905) Polymorphonuclear cells [#/volume] in Blood

1.44

0.53

2.4

3.6

e9/l

3.9

4.4

0.39

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

399

1.19

0.51

1.8

2.4

ml/min/173m2

72.1

71.1

0.05

152

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

235

1.25

0.49

1.5

1.4

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

1.41

0.48

2.5

4.2

55.8

57.1

0.17

(1616796) Gas panel - Central venous blood

1.39

0.46

3.6

—

(40761536) Microorganisms panel - Urine sediment

425

0.84

0.44

5.6

3.5

—

(3012501) Base excess in Blood by calculation

1.38

0.44

5.2

4.2

mmol/l

2.9

2.6

0.15

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

1.62

0.43

1.4

2.0

10.8

12.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

122

1.32

0.42

1.8

1.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

351

1.18

0.42

1.1

1.2

—

(40768804) Tissue Pathology biopsy report

204

2154

0.92

0.41

2.2

2.0

—

(21494814) CD8 cells/100 lymphocytes in Specimen

0.00

0.41

0.0

1.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

0.00

0.40

0.0

1.2

—

6.9

—

(3047189) Immunofixation for 24 hour Urine

0.00

0.40

0.0

1.9

—

(40768800) Prostate Pathology biopsy report

1.34

0.40

1.4

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1.37

0.40

1.1

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1.37

0.40

1.1

1.4

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

1.9

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.40

0.0

1.0

—

27.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

1.41

0.39

2.6

—

(3051611) Lipemic interference index of Serum or Plasma

1.43

0.39

4.6

3.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

737

1.11

0.37

3.1

2.4

e6/l

1.6

0.9

0.37

393

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1.29

0.36

1.7

1.1

—

(3019230) Fractional oxyhemoglobin in Venous blood

0.64

0.36

3.8

2.0

73.2

62.1

—

(4034850)

181

1.22

0.35

13.8

7.9

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

895

1.10

0.35

1.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1.35

0.34

1.2

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

200

1.21

0.34

10.9

12.0

mmol/l

24.8

24.5

0.13

192

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1.32

0.34

1.7

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

0.69

0.33

1.0

1.5

—

(3049717) Cytology report of Urine Cyto stain

128

1.26

0.32

2.4

2.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1.31

0.32

1.2

u/ml

5.3

7.8

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

474

0.88

0.32

3.9

4.4

ug/l

2.9

23.8

1.24

376

(3024928) Oxygen saturation in Venous blood

1.30

0.30

3.4

2.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

129

0.77

0.28

3.6

2.9

mg/l

1.7

1.5

—

117

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.29

0.28

1.0

1.6

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

1.23

0.27

1.8

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1.27

0.26

1.0

u/ml

0.3

0.7

—

(3000330) Specific gravity of Urine by Test strip

207

1.17

0.25

2.2

2.9

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1.20

0.25

1.4

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

588

0.91

0.24

1.7

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

649

0.92

0.23

1.3

1.4

—

(1002224) Polysomnography panel

274

0.87

0.23

1.1

—

(3045424) Erythrocytes [Presence] in Urine

1.25

0.22

1.4

1.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

818

1.07

0.22

2.3

2.8

mmol/l

2.4

0.39

729

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

163

1.17

0.21

1.1

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.21

0.0

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.00

0.21

0.0

1.8

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.8

—

98.9

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.21

0.0

1.3

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

0.00

0.21

0.0

1.1

—

1.9

—

(40758292) HTLV I+II Ab panel - Serum

0.00

0.21

0.0

1.4

—

(44813793)

1.16

0.21

1.0

—

(3021440) Promyelocytes/100 leukocytes in Blood

397

0.90

0.21

3.3

4.8

0.0

0.1

3.61

109

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

0.00

0.21

0.0

1.5

—

66.0

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

0.00

0.21

0.0

1.5

—

511.7

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

134

0.82

0.21

1.1

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

0.00

0.20

0.0

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

1.23

0.20

1.0

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

119

1.18

0.18

1.1

u/ml

0.1

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.72

0.17

1.0

1.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

101

1.19

0.16

1.0

u/ml

21.4

5.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

369

0.92

0.15

2.8

3.7

mmol/l

1.2

0.16

314

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1.10

0.15

1.1

1.8

—

(3000492) Spirometry study

552

0.94

0.14

1.3

1.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

112

1.16

0.14

4.6

2.3

u/ml

0.4

0.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

100

0.80

0.13

1.4

1.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

130

1263

1.04

0.12

3.5

4.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

383

0.94

0.11

3.1

4.5

0.7

0.5

0.32

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

1.09

0.09

2.0

1.8

—

7.6

—

(3035285) Chloride [Moles/volume] in Venous blood

1.06

0.09

1.4

2.9

mmol/l

105.4

105.2

—

(3041354) Potassium [Moles/volume] in Venous blood

1.06

0.09

1.4

2.9

mmol/l

3.8

4.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1.06

0.09

1.4

2.9

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

1.04

0.09

1.0

1.1

—

(3003694) ABO and Rh group [Type] in Blood

150

1532

0.97

0.09

1.4

1.5

—

(3025130) Human papilloma virus identified in Specimen

1.14

0.09

1.4

1.8

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.80

0.08

1.0

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

0.78

0.08

1.0

1.1

g/l

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

164

0.91

0.08

1.2

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

1.08

0.07

1.1

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1.05

0.07

1.3

1.0

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

710

0.97

0.06

3.2

2.6

e6/l

2.6

3.2

0.17

368

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.84

0.06

1.3

1.2

—

(3025159) Blasts/100 leukocytes in Blood

376

0.95

0.06

3.2

4.9

0.0

0.2

1.11

(3003740) Influenza virus B Ag [Presence] in Specimen

120

0.92

0.05

1.2

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

120

0.92

0.05

1.2

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

423

0.97

0.04

3.0

4.6

0.8

1.0

0.23

124

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

521

5196

1.02

0.03

4.2

3.6

mmol/l

1.5

1.3

2.89

491

4855

(4094501)

132

1.06

0.02

1.1

1.0

—

(3002256) Pathology report gross observation

659

0.98

0.02

1.2

—

(40768793) Breast Pathology biopsy report

149

1.01

0.00

1.4

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

209

1.00

0.00

1.8

1.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

112

1122

1.00

0.00

1.5

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

319

1.00

0.00

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.95

0.00

1.1

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

0.95

0.00

3.0

2.8

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.0

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

0.0

1.0

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.0

—

54.8

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

0.00

0.0

6.0

—

0.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

0.0

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

0.0

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.00

0.0

3.2

—

(3001729) Color of Synovial fluid

0.00

0.0

1.4

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.0

3.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.0

1.3

—

2.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.0

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

0.00

0.0

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.9

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.4

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.0

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

0.88

0.00

1.1

1.2

u/l

9.6

30.3

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.91

0.00

1.0

2.1

30.6

32.5

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.00

0.0

1.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.0

7.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.0

1.6

—

321.0

—

(44806420)

0.00

0.0

3.1

—

(4281824)

1.02

0.00

1.0

1.1

—

(3003129) Base excess in Capillary blood by calculation

0.00

0.0

1.1

—

2.6

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

0.00

0.0

2.9

—

(3014891) Appearance of Pleural fluid

0.00

0.0

1.0

—

(3000285) Sodium [Moles/volume] in Blood

0.00

0.0

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.00

0.0

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_CAUSALGIA and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_CAUSALGIA	1.273 [1.05, 1.54]	0.013
Birth year	0.999 [0.99, 1.01]	0.825

During the follow-up period (1.1.1998 — 31.12.2019), 162 out of 2156 females with G6_CAUSALGIA died.

Males

Parameter	HR [95% CI]	p-value
G6_CAUSALGIA	1.295 [1.08, 1.56]	0.006
Birth year	0.987 [0.98, 1.0]	0.007

During the follow-up period (1.1.1998 — 31.12.2019), 165 out of 1325 males with G6_CAUSALGIA died.

Mortality risk

Mortality risk for people of age

years, who have G6_CAUSALGIA.

N-year risk	Females	Males
1	0.137%	0.213%
5	0.811%	1.374%
10	2.068%	3.589%
15	3.917%	6.907%
20	6.745%	11.677%

Relationships between endpoints

↥

Index endpoint: G6_CAUSALGIA – Causalgia

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Causalgia

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints